These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10328974)

  • 1. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
    Sato S; Sugiyama K; Lee YS; Kador PF
    Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
    Sato S
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S; Sugiyama K; Carper D
    Adv Exp Med Biol; 1997; 414():499-505. PubMed ID: 9059655
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone.
    Sugiyama K; Wang TC; Simpson JT; Rodriguez L; Kador PF; Sato S
    Drug Metab Dispos; 1999 Jan; 27(1):60-7. PubMed ID: 9884310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV; Takahashi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes.
    Tao RV; Holleschau AM; Rathbun WB
    Ophthalmic Res; 1991; 23(5):272-83. PubMed ID: 1784459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a naphthalene cataract model in vitro.
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):73-81. PubMed ID: 1541343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of aldose reductase in naphthalene cataract.
    Lee AY; Chung SS
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis).
    Murata M; Ohta N; Sakurai S; Alam S; Tsai J; Kador PF; Sato S
    Chem Biol Interact; 2001 Jan; 130-132(1-3):617-25. PubMed ID: 11306080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene.
    Saeed M; Higginbotham S; Rogan E; Cavalieri E
    Chem Biol Interact; 2007 Feb; 165(3):175-88. PubMed ID: 17224140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.